YOUNG KWON - 19 Feb 2025 Form 4 Insider Report for ADMA BIOLOGICS, INC. (ADMA)

Role
Director
Signature
/s/ Young Kwon, by Adam S. Grossman as Attorney-in-fact
Issuer symbol
ADMA
Transactions as of
19 Feb 2025
Net transactions value
$0
Form type
4
Filing time
21 Feb 2025, 21:05:33 UTC
Previous filing
27 Aug 2024
Next filing
11 Feb 2026
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADMA Common Stock Award $0 -10,889 -4.1% $0.000000 252,330 19 Feb 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADMA Stock Option (right to buy) Award $0 +16,279 $0.000000 16,279 19 Feb 2025 Common Stock 16,279 $16.07 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares represent restricted stock units ("RSUs") that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the Reporting Person's continued service as of the applicable vesting date.
F2 Includes, as of the transaction date, (i) 10,889 RSUs granted on February 19, 2025 and reported on this Form 4, subject to vesting as set forth in footnote (1); (ii) 12,020 RSUs granted on February 26, 2024, which will vest in full on February 26, 2024, subject to the Reporting Person's continued service as of such vesting date; and (iii) 229,421 shares of common stock owned by the reporting person.
F3 The options vest in 12 equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant.